Bruce J. Brew

Bruce J. Brew

St. Vincent's Hospital
Darlinghurst, NSW, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 188 publications

Sources of Active Brain White Matter Injury in Virally Suppressed HIV Infection Revealed Through Fixel-Based Analysis.

Sources of Active Brain White Matter Injury in Virally Suppressed HIV Infection Revealed Through Fixel-Based Analysis.

Journal: Journal of acquired immune deficiency syndromes (1999)
Published: August 06, 2026

Measuring neurocognitive impairment in virally suppressed HIV: HIV-associated neurocognitive disorders, HIV-associated brain injury problems and solutions.

Measuring neurocognitive impairment in virally suppressed HIV: HIV-associated neurocognitive disorders, HIV-associated brain injury problems and solutions.

Journal: Current opinion in HIV and AIDS
Published: July 06, 2026

Neuroinfectious diseases in 2025: pathogens old and new.

Neuroinfectious diseases in 2025: pathogens old and new.

Journal: The Lancet. Neurology
Published: November 20, 2025

Persistent cell-associated HIV-1 RNA in virally suppressed individuals on INSTI-based ART.

Persistent cell-associated HIV-1 RNA in virally suppressed individuals on INSTI-based ART.

Journal: Journal of virus eradication
Published: July 11, 2025

Editorial: Viral impact on CNS: mechanisms of immune dysfunction and cognitive decline.

Editorial: Viral impact on CNS: mechanisms of immune dysfunction and cognitive decline.

Journal: Frontiers in immunology
Published: June 03, 2025

Renal and hepatic function is preserved following inducible knockout of kynurenine pathway enzymes KMO or QPRT in adult mice.

Renal and hepatic function is preserved following inducible knockout of kynurenine pathway enzymes KMO or QPRT in adult mice.

Journal: PloS one
Published: May 14, 2025

Neuropathogenesis of acute HIV: mechanisms, biomarkers, and therapeutic approaches.

Neuropathogenesis of acute HIV: mechanisms, biomarkers, and therapeutic approaches.

Journal: Current opinion in HIV and AIDS
Published: March 20, 2025

Neuroinflammation associated with proviral DNA persists in the brain of virally suppressed people with HIV.

Neuroinflammation associated with proviral DNA persists in the brain of virally suppressed people with HIV.

Journal: Frontiers in immunology
Published: February 04, 2025

Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial.

Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial.

Journal: The journal of prevention of Alzheimer's disease
Published: January 12, 2025

Altered blood-brain barrier permeability is associated with abnormal distant connectivity and regional homogeneity in covert hepatic encephalopathy-A cross-sectional study.

Altered blood-brain barrier permeability is associated with abnormal distant connectivity and regional homogeneity in covert hepatic encephalopathy-A cross-sectional study.

Journal: Hepatology (Baltimore, Md.)
Published: December 09, 2024

Deferiprone in Alzheimer Disease: A Randomized Clinical Trial.

Deferiprone in Alzheimer Disease: A Randomized Clinical Trial.

Journal: JAMA neurology
Published: November 04, 2024

Higher levels of cell-associated HIV-1 RNA transcripts predict risk of viral blips: implications for clinical management and cure research.

Higher levels of cell-associated HIV-1 RNA transcripts predict risk of viral blips: implications for clinical management and cure research.

Journal: AIDS (London, England)
Published: October 09, 2024
Showing 1-12 of 188

Last Updated: 09/26/2026